Here we describe some of the fundamental aspects of formulation design applicable to virus-like-particle based vaccine antigens (VLPs).
Aspects of formulation development and preclinical and clinical evaluation of rectal products studied to date are summarized in this review.
Drug companies often file patent upon patent upon patent for the same drug, protecting different aspects of formulation, different clinical applications, or even the chemicals that the body turns the drug into once it has been taken.
Several aspects of formulation are considered, such as pre-screening, choosing excipient(s), the effect of polymer structure on performance, formulation optimisation, ternary dispersions, fixed-dose combinations, solvent selection and component miscibility.
This review provides a comprehensive and up-to-date analysis of oral dosage forms considering key aspects of formulation design including dosage considerations, ease of use, tolerability and safety, manufacturing complexity, stability, supply and cost.
This presentation will examine aspects of formulation design, types of robust dosage forms to consider, effective routes of delivery (invasive and noninvasive), and distinctions between live attenuated or inactivated vaccines.
All the important industrial aspects of formulation are covered from the initial choice of catalytic species, through the processes of fabrication of the catalyst to its final reduction in the reactor.
General desirable aspects of formulations include safety (e.g. isosmolar aqueous gels), efficacy, stability, and patient acceptability.
The skin anti-aging aspect of the formulation integrates multiple ingredients addressing all major known mechanisms involved in the process.
